Light imaging contrast agents

Details Light imaging contrast agents Light imaging contrast agents

2006-03-21

2006-03-21

Hartley, Michael (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Diagnostic or test agent produces in vivo fluorescence

C424S009610, C424S009100

Reexamination Certificate

active

07014839

ABSTRACT:
The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.

REFERENCES:
patent: 5460800 (1995-10-01), Walters
patent: 5650135 (1997-07-01), Contag et al.
patent: 6028066 (2000-02-01), Unger
patent: 0 312 108 (1989-04-01), None
patent: 0 338 971 (1989-10-01), None
patent: 0 446 028 (1991-09-01), None
patent: 2 118 178 (1972-07-01), None
patent: 2 184 015 (1987-06-01), None
patent: WO94/18954 (1994-09-01), None
Jain, R. K., “Barriers to Drug Delivery in Solid Tumors” Scientific American, vol. 271, No. 1, Jul. 1, 1994 pp. 42-49.
Bjerknes, R., et al. “Human Leucocyte Phagocytosis of Zymosan Particles Measured by Flow Cytometry” ACTA Pathol. Microbiol. Immunol. Scand., vol. 91, No. 5, 1983 pp. 341-348.
Cheng, K. T., “The Production and Evaluation of Contrast-Carrying Liposomes made with an Automatic High-Pressure System” Investigative Radiology, vol. 22, No. 1, Jan. 1987 pp. 47-55.

Affiliated with

Also associated with

Rating

Light imaging contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Light imaging contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Light imaging contrast agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3534919